周教授：在临床实践中，若新疗法无法改善患者的生活质量，则不应被常规采纳。我们应给予患者报告结局（PRO）更多关注，因为生活质量对患者来说很重要。

 

Ruffini教授：我完全赞同。在浏览2025 ELCC壁报时，我发现一些研究探索了生活质量指标这个关键议题。我们现已建立完善的评估体系来衡量生活质量，这正是"以患者为中心"医疗理念的核心要义——让患者成为治疗的中心焦点。若真正践行这一理念，就意味着必须将生活质量纳入关键考量维度。如果一种方案“治愈”患者却同时摧毁其生活质量，那么这种治疗毫无价值，我们必须在疗效与生存质量之间取得平衡。

 

Dr.Zhou:That’s a great question.How we treat our patients should improve quality of life.If a new therapy does not improve quality of life，it is not acceptable in our daily practice.Quality of life is very important.We should pay more attention to patient-reported outcomes.

 

Dr.Ruffini:Yes，I cannot agree more.I had a look at the posters，for example，and some posters addressed this very important issue–quality of life.We have metrics to measure quality of life.This is part of what we call patient-centered medicine–to put the patient at the center of our cure.If we want to put the patient at the center of our treatment process，this means also taking into account the quality of life.In my opinion，it is completely worthless to cure a patient，but at the same time，destroy the patient–to reduce the patient to a very poor quality of life，psychologically or functionally.We need to provide a balance in that regard.For this reason，I think your question is very pertinent.